Skip to content
In English |
En español
National Cancer Institute
at the National Institutes of Health
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat
Popular Resources
Help Using the NCI Clinical Trials Search Form
How to Find a Cancer Treatment Trial
Learn About Clinical Trials
About NCI's List of Cancer Clinical Trials
NCI Dictionary of Cancer Terms
NCI Drug Dictionary
Featured Clinical Trials Supported by NCI
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-9 of 9 for your search:
Drug:
azathioprine sodium
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-Based Immunosuppressive Protocol
Phase:
Phase IV
Type:
Prevention
Status:
Closed
Age:
18 and over
Sponsor:
Other
Protocol IDs:
PROSKIN 01
, NCT00866684
2.
Phase III Chemotherapy with BCNU/CTX/PRED Followed by ADR/VCR/ATP/PRED vs No Therapy vs L-PAM/PRED for Previously Untreated Multiple Myeloma
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
no age specified
Sponsor:
Protocol IDs:
SEG-76MM311
, SEG-76MM0203
3.
Phase III Chemotherapy with L-PAM/CTX/BCNU/PRED and Azathioprine/PRED for Remission Maintenance of Multiple Myeloma
Phase:
Phase III
Type:
Treatment
Status:
Completed
Age:
no age specified
Sponsor:
NCI
Protocol IDs:
SWOG-7313
4.
Phase III Bone Marrow Transplant Protocol for Children with Relapsed ALL in Remission after Treatment on SIMAL #5: Pretreatment with High-Dose ARA-C, Fractionated TBI, and Testicular Irradiation (Summary Last Modified 01/88)
Phase:
Phase III
Type:
Treatment
Status:
Closed
Age:
21 and under
Sponsor:
NCI
Protocol IDs:
POG-8711
5.
Phase I/II Study of Ablative Chemotherapy with ARA-C/CTX, TBI, and Syngeneic/Allogeneic Bone Marrow Transplantation for Chronic Myelogenous Leukemia
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Closed
Age:
15 to 45
Sponsor:
Protocol IDs:
SEG-CML-83215L
, SEG-CML-83-215L
6.
Phase II Pilot Study of High-Dose ARA-C, Fractionated TBI, and Bone Marrow Transplantation in Childhood ALL
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
1 to 21
Sponsor:
NCI
Protocol IDs:
POG-8319
7.
Phase II Pilot Allogeneic or Autologous Bone Marrow Transplantation for Stage D Neuroblastoma in Remission (Summary Last Modified 10/88)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
1 to 21
Sponsor:
NCI
Protocol IDs:
POG-8340
8.
Phase II Study of High-Dose ARA-C, Fractionated TBI, and Allogeneic BMT without GVHD Prophylaxis in Patients with AML and ALL in Second or Subsequent Remission or Early Relapse
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
15 to 35
Sponsor:
Protocol IDs:
SEG-LEU-207
9.
Phase II Multicenter Study of Syngeneic/Allogeneic Bone Marrow Transplantation from HLA-Identical Siblings Following Ablation with Ara-C/CY and Total-Body Irradiation for Patients with CML in Chronic, Accelerated, or Second Chronic Phase after Blast Phase (Summary Last Modified 04/90)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 to 50
Sponsor:
Protocol IDs:
CWRCC-ICC-1486
, NCI-V88-0445
Select All on Page
Help with Results
We Can Answer Your Questions
1-800-4-CANCER
LiveHelp Online Chat
NCI Home
Contact Us
Policies
Accessibility
Viewing Files
FOIA
Site Help
Site Map
Follow Us:
Twitter
YouTube
Facebook
RSS
Other Versions:
Mobile
|
Español
U.S. Department of Health and Human Services
National Institutes of Health
National Cancer Institute
USA.gov
NIH…Turning Discovery Into Health
®